Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
ClinicalTrials.gov study NCT06690216. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03025542. IPD Sharing: Not stated. Countries: 4. Publications: 2.
A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers
ClinicalTrials.gov study NCT03446053. IPD Sharing: NO. Countries: 1. Publications: 4.
PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
ClinicalTrials.gov study NCT03132636. IPD Sharing: Not stated. Countries: 10. Publications: 5.
A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day
ClinicalTrials.gov study NCT01072149. IPD Sharing: YES. Countries: 1. Publications: 1.
Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy
ClinicalTrials.gov study NCT02913482. IPD Sharing: YES. Countries: 16. Publications: 5.
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT01723774. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors
ClinicalTrials.gov study NCT03250832. IPD Sharing: NO. Countries: 2. Publications: 1.
Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies
ClinicalTrials.gov study NCT04181788. IPD Sharing: YES. Countries: 6. Publications: 1.
Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer
ClinicalTrials.gov study NCT02129556. IPD Sharing: Not stated. Countries: 5. Publications: 5.
Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Modera
ClinicalTrials.gov study NCT01494610. IPD Sharing: YES. Countries: 2. Publications: 1.
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
ClinicalTrials.gov study NCT03474640. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02793856. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.
ClinicalTrials.gov study NCT01929317. IPD Sharing: YES. Countries: 1. Publications: 1.
Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer
ClinicalTrials.gov study NCT03409614. IPD Sharing: Not stated. Countries: 18. Publications: 3.
Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7
ClinicalTrials.gov study NCT03776136. IPD Sharing: YES. Countries: 5. Publications: 1.
Open-Label Safety Study of ADS-5102 in PD Patients With LID
ClinicalTrials.gov study NCT02202551. IPD Sharing: Not stated. Countries: 6. Publications: 29.
Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).
ClinicalTrials.gov study NCT04068181. IPD Sharing: YES. Countries: 11. Publications: 1.
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhi
ClinicalTrials.gov study NCT03016312. IPD Sharing: Not stated. Countries: 21. Publications: 1.
Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03197467. IPD Sharing: NO. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.